FDA Inspection 1169079 — Daniel M. Duncanson, M.D.
The FDA completed an inspection of Daniel M. Duncanson, M.D. on Apr 28, 2022 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 28, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Gainesville, FL (United States)
Additional Details
Clinical Investigator (CI)